Articles | Volume 4, issue 5
https://doi.org/10.7150/jbji.37980
© Author(s) 2019. This work is distributed under the Creative Commons Attribution 4.0 License.
Case report
| 
15 Oct 2019
Case report |
| 15 Oct 2019
| 15 Oct 2019
Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
Keywords: Periprosthetic joint infection, Lipoglycopeptide, Coagulase negative staphylococcus epidermidis, Osteomyelitis
Abstract. We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dosing.
